Burden of Illness of Diabetic Peripheral Neuropathic Pain: A Qualitative Study

Patient

Volumn 8, Issue 4, 2015, Pages 339-348

  Brod, Meryl ^a   Pohlman, Betsy ^a   Blum, Steven I ^c   Ramasamy, Abhilasha ^b   Carson, Robyn ^b  

^a Brod Group   (United States)

^b FOREST RESEARCH INSTITUTE   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; AROUSAL; ARTICLE; DEPRESSION; DIABETIC PERIPHERAL NEUROPATHIC PAIN; DISEASE DURATION; ENERGY; EXERCISE; FALLING; FEAR; FEMALE; FUNCTIONAL STATUS; HUMAN; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PRODUCTIVITY; QUALITATIVE RESEARCH; RECREATION; SLEEP; SOCIAL INTERACTION; SYMPTOM; TELEPHONE INTERVIEW; WALKING; WALKING DIFFICULTY; WELLBEING; DAILY LIFE ACTIVITY; DIABETIC NEUROPATHY; HEALTH STATUS; INTERVIEW; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; SOCIAL PARTICIPATION;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; DIABETIC NEUROPATHIES; FEMALE; HEALTH STATUS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MOBILITY LIMITATION; QUALITATIVE RESEARCH; QUALITY OF LIFE; SLEEP; SOCIAL PARTICIPATION;

EID: 84938824158     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-014-0093-9     Document Type: Article

References (38)

1. Tesfaye S, Vileikyte L, Rayman G, Sindrup S, Perkins B, Baconja M, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011;. doi:10.1002/dmrr.1225.
2. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5.
3. Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152:14–27.
4. Argoff CE, Cole BE, Fishbain DA, Irving GA. Diabetic peripheral neuropathic pain: clinical and quality of life issues. Mayo Clin Proc. 2006;81:S3–11.
5. Cole BE. Diabetic peripheral neuropathic pain: recognition and management. Pain Med. 2007;8:S27–32.
6. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123–8.
7. Armstrong DG, Chappell AS, Le TK, Kajdasz DK, Backonja M, D’Souza DN, et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evalution of functional outcomes. Pain Med. 2007;8:410–8.
8. Boulton AJ. What you can’t feel can hurt you. J Vasc Surg. 2010;52:28S–30S.
9. Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30:374–85.
10. Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain. 2006;22:681–5.
11. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev. 2003;19(Suppl 1):S2–8.
12. Iyer S, Tanenberg RJ. Pharmacologic management of diabetic peripheral neuropathic pain. Expert Opin Pharmacother. 2013;14:1765–75.
13. Vinik A, Zlateva G, Cheung R, Murphy K, Emir B, Whalen E. Understanding the impact of pain response on changes in function, quality of life, and sleep interference in patients with painful diabetic peripheral neuropathy and post-herpetic neuralgia treated with pregabalin. J Pain. 2010;11:S17.
14. Vinik A, Emir B, Cheung R, Whalen E. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin. Clin Ther. 2013;35:612–23.
15. Toth C, Mawani S, Brady S, Chan C, Liu C, Mehina E, et al. An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain. Pain. 2012;153:2073–82.
16. Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain. 2007;23:150–8.
17. Baron R, Brunnmüller U, Brasser M, May M, Binder A. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: open-label, non-comparative, flexible-dose study. Eur J Pain. 2008;12:850–8.
18. Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 2007;8:S50–62.
19. Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM. 1998;91:733–7.
20. Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, et al. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia. 2006;49:2272–80.
21. Jensen TS, Backonja MM, Hernández Jiménez S, Tesfaye S, Valensi P, Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diabees Vasc Dis Res. 2006;3:108–19.
22. Sullivan MJ, Lynch ME, Clark AJ. Dimensions of catastrophic thinking associated with pain experience and disability in patients with neuropathic pain conditions. Pain. 2005;113:310–5.
23. Tölle T, Xu X, Sadosky AB. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complicat. 2006;20:26–33.
24. Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009;35:206–13.
25. Vileikyte L, Leventhal H, Gonzalez JS, Peyrot M, Rubin RR, Ulbrecht JS, et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care. 2005;28:2378–83.
26. Ahroni JH, Boyko EJ. Responsiveness of the SF-36 among veterans with diabetes mellitus. J Diabetes Complicat. 2000;14:31–9.
27. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, et al. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25:2238–43.
28. Gore M, Brandenburg NA, Hoffman DL, Tai KS, Stacey B. Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. J Pain. 2006;7:892–900.
29. IndINeP Study Group. Burden of neuropathic pain in Indian patients attending urban, specialty clinics: results from a cross sectional study. Pain Pract. 2008;8:362–78.
30. Lewko J, Polityńska B, Kochanosicz J, Zarzycki W, Okruszko A, Sierakowska M, et al. Quality of life and its relationship to the degree of illness acceptance in patients with diabetes and peripheral diabetic neuropathy. Adv Med Sci. 2007;52:144–6.
31. Hoffman DL, Sadosky A, Alvir J. Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East. Pain Pract. 2009;9:35–42.
32. Argoff CE, Backonja MM, Belgrade MJ, Bennett GJ, Clark MR, Cole BE, et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc. 2006;81:S12–25.
33. Vileikyte L, Peyrot M, Gonzalez JS, Rubin RR, Garrow AP, Stickings D, et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia. 2009;52:1265–73.
34. daCosta DiBonaventura M, Cappelleri JC, Joshi AV. A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. Pain Med. 2011;12:118–26.
35. atlas.ti. Qualitative data analysis. ATLAS.ti Scientific Software Development GmbH Germany. 2014. http://www.atlasti.com/index.html. Accessed 13 Jan 2014.
36. Brod M, Tesler LE, Christensen T. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18:1263–78.
37. Saldana J. The coding manual for qualitative researchers. Los Angeles: Sage; 2010.
38. Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL, et al. The development and validation of the Norfolk QOL-DN, a new measure of patients’ perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther. 2005;7:497–508.